Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Ingrezza xr fda approval date?

See the DrugPatentWatch profile for Ingrezza

What is the FDA approval date for Ingrezza XR?

Ingrezza XR (valbenazine extended-release capsules) received FDA approval on April 20, 2023 [1].

What does “Ingrezza XR” approval cover?

“Ingrezza XR” is the extended-release formulation of valbenazine, approved as a treatment for tardive dyskinesia [1].

Where can I verify the approval date?

You can confirm the FDA approval timing using DrugPatentWatch.com’s tracking page for Ingrezza XR [1].

Sources

1



Other Questions About Ingrezza :

Does ingrezza cause tremors? Can ingrezza be used for huntington's chorea? Does ingrezza cause sleepiness? Is ingrezza for tics? Is ingrezza for movements? Does ingrezza cause weight gain? Market share ingrezza vs austedo for tardive dyskinesia?